AUS
NZ
UK
CA
USA
IND
Healthcare
Antisense’s Stocks Surged On ASX After The Announcement Of Phase 2 Clinical Trial for DMD
January 18, 2019 05:00 PM AEDT| By Team Kalkine MediaAntisense Therapeutics Limited (ASX: ANP) is a biopharmaceutical company which is primarily into the discovery and development of drugs. The company has an objective to create, develop and commercialize novel antisense pharmaceuticals patients with d...
MGC Pharmaceuticals’ Shares Uplifted On ASX After Publishing Its Quarterly Activity Report
January 18, 2019 03:53 PM AEDT| By Team Kalkine MediaMGC Pharmaceuticals Ltd (ASX: MXC) wants to be an innovator in the global Phytocannabinoid-based medicine. It has technical and professional experience of several years. The company wants to create and supply high-quality Cannabinoid based pharmaceut...
Genera Biosystems Obtains Decent R&D Tax Rebate ($438,087) From ATO
January 17, 2019 08:00 PM AEDT| By Team Kalkine MediaOn 17 January 2019, the Board of Genera Biosystems Limited (ASX: GBI) announced that the company has been granted $438,087 R&D Tax Incentive rebate by Australian Taxation Authority for 2018 financial year, which includes an amount payable that wa...
Pharmaxis’ Shares Uplifted On ASX As Its Inhibitor Program Is Ready To Enter Phase 2 Clinical Studies
January 17, 2019 07:18 PM AEDT| By Team Kalkine MediaThe Pharmaceutical research company, Pharmaxis Limited (ASX: PXS) made an announcement on 17 January 2019 stating that it has received reports on all of the 13?week toxicity studies conducted for each of its two Lysyl Oxidase Like 2 (LOXL2) inhibitor...
Anteo Diagnostics Signs Collaboration with Sona Nanotech – What Investors Need to Know
January 17, 2019 07:07 PM AEDT| By Team Kalkine MediaAnteo Diagnostics Limited (ASX: ADO) is a nanotechnology company. It is into development and commercializing of products in the life sciences research, diagnostics, energy and in the market for medical devices. Anteo Technologies Pty Ltd is a fully-o...
Why These Two Healthcare Stocks Spiked Up In Last 5 Trading Days – HMD And KZA?
January 17, 2019 04:07 PM AEDT| By Team Kalkine MediaHeraMED Limited?(ASX: HMD) HeraMED Limited?(ASX: HMD) is a technology-driven healthcare company which provides innovative pregnancy monitoring solutions to its customers. In December 2018, the company was listed on ASX after the successful completio...
Cannabis License From The Health Department May Enhance Impression Healthcare’s Operations
January 16, 2019 06:17 PM AEDT| By Team Kalkine MediaImpression Healthcare Limited (ASX: IHL) is into the business of providing high quality, personalized dental health care products to its consumers. It is a nation-wide service provider to individuals, schools and sports clubs. It is capable of large-...
The Share Price Of RHT Zoomed Up By 10% After The Execution Of The Distribution Agreement
January 15, 2019 11:15 PM AEDT| By Team Kalkine MediaResonance Health Limited (ASX: RHT), a medical device software company from the health care equipment & services sector announced that it entered into a distribution agreement with EnvoyAI Inc, a US Delaware Corporation for the distribution of RH...
Prescient Therapeutics Announces The Receipts of R&D Tax Rebate
January 15, 2019 06:38 PM AEDT| By Team Kalkine MediaOn 15 January 2019, Prescient Therapeutics Limited (ASX: PTX) announced that the company had received Tax Incentive rebate on research and development for the financial year 2017-2018, amounting to $939,423. The R&D Tax Incentive is an Australian...
CardieX Limited’s Stock Zooms Up On Executing Co-Marketing Agreement With US Health Insurer
January 15, 2019 04:06 PM AEDT| By Team Kalkine MediaCardieX Limited (ASX: CDX) announced the execution of Co-marketing agreement between inHealth Medical Services Inc and Anthem Inc to jointly promote the services of inHealth across Anthem?s healthcare and health insurance networks in the United State...
Kazia Therapeutics Receives $2.2 Million R&D Cash Rebate From ATO
January 15, 2019 03:23 PM AEDT| By Team Kalkine MediaOn 15 January 2019, Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA) announced that it has received approximately $2.2 million cash rebate from the Australian Taxation Office under the R&D Tax Incentive Program for the financial year ending 30...
Clinuvel Update: Regulatory Timeline, Expansion Plans For SCENESSE® (afamelanotide 16mg)
January 15, 2019 02:15 PM AEDT| By Team Kalkine MediaOn 15 January 2019, Clinuvel Pharmaceuticals Limited (ASX: CUV) announced major timelines for the FDA approvals on the overall benefit-risk assessment of SCENESSE? (afamelanotide 16mg), company?s flagship photoprotective drug for the prevention of ph...
Healthcare Stocks Under Focus- HMD And MSB
January 14, 2019 11:21 PM AEDT| By Team Kalkine MediaThe below mention stocks are part of Australia?s biggest industry, i.e., Healthcare Industry. In the recent past, these healthcare stocks have made significant progress in their strategic objectives. Let?s take a closer look at these stocks- HeraMED...
Noxopharm’s Shares Uplifted 15% On ASX After Providing Update On Its LuPIN-1 Study
January 14, 2019 05:20 PM AEDT| By Team Kalkine MediaClinical-stage Australian drug development company, Noxopharm Limited (ASX: NOX) has released an interview with Associate Professor Louise Emmett who is the co-Principal Investigator of the LuPIN-1 Study which is being conducted at St Vincent?s Hospi...
Capitol Health Announced The Acquisition Of 4 Clinics In Metropolitan Melbourne From Uniradiology
January 14, 2019 02:12 PM AEDT| By Team Kalkine MediaOn 14 January 2019, Australia?s leading provider of diagnostic imaging and related services, Capitol Health Limited (ASX: CAJ) announced the acquisition of a network of 4 clinics in metropolitan Melbourne from Uniradiology. Despite this news, the sha...
2 Small-Cap Healthcare Stocks – BIT And BNO
January 11, 2019 11:11 PM AEDT| By Team Kalkine MediaHealthcare industry is one of the biggest industries in Australia and investors should always keep a close eye on the stocks that are part of this Industry. The below mentioned two Healthcare Stocks have made some key strategic progress in the recent...
Nanollose Secured a Development Facility to Increase its Microbial Cellulose Production
January 10, 2019 07:45 PM AEDT| By Team Kalkine MediaToday (i.e., 10 January 2019), leading research and development company, Nanollose Limited (ASX: NC6), announced that it has secured a development facility for scale-up of microbial cellulose production. To increase its commercial-scale fibre product...
FDA Sets Prescription Drug User Fee Act (PDUFA) Date For CLINUVEL’s SCENESSE®
January 10, 2019 04:42 PM AEDT| By Team Kalkine MediaA global biopharmaceutical company, CLINUVEL Pharmaceuticals Limited (ASX: CUV) is in the process of getting approval from US Food and Drug Administration (FDA) for CLINUVEL?s lead compound, SCENESSE? (afamelanotide 16mg), a first-in-class drug targe...
Justice Health Ties Up With Global Health For MasterCare EMR
January 10, 2019 04:34 PM AEDT| By Team Kalkine MediaOn 10 December 2018, Global Health Limited (ASX: GLH) announced the execution of an agreement with Justice Health for the deployment of MasterCare Electronic Medical Record (EMR). The agreement is for a minimum term of 3 years with two further extens...
Launch Of Nuheara’s IQconnect Enhances Customer Hearing Journey
January 10, 2019 04:05 PM AEDT| By Team Kalkine MediaNuheara Limited (ASX: NUH) is a wearable technology company based in Perth, Australia. It has two other offices located in the USA, one in San Francisco and the other in New York. It is one of the leading companies in the world providing smart person...
Advertise your brand on Kalkine Media